ScholarIQanswers from OpenAlex

Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event

PaperCitations, authors & open-access status

Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event have?

ScholarIQcitation count

Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event has 34 citations in the OpenAlex counts ScholarIQ stores.

When was Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event published?

ScholarIQyear

Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event has 2023 year in the ScholarIQ index.

What is the open-access status of Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event?

ScholarIQoa status

Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event has closed oa status in the ScholarIQ index.

What is the DOI of Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event?

ScholarIQdoi

The DOI for Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event is on the source record.

What is the PMID of Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event?

ScholarIQpmid

The PMID for Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event is on the source record.

What is the OpenAlex record for Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event?

ScholarIQopenalex

The OpenAlex for Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial